HENOCH-SCHONLEIN PURPURA IN CHILDREN: OUR EXPERIENCE WITH 165 CASES FROM SOUTHERN IRAN
Authors
Abstract:
During a 6 year period from September 1992 to September 1998, 165 children with a final diagnosis of Henoch-Schonlein purpura (HSP) were managed and followed in our center. There were 87 (52%) boys and 78 (48%) girls, with age ranges of 1-16 years and mean age of 7.8 years. Forty-one percent of the patients had evidence of preceding upper respiratory tract infection (URI). The main clinical features were: skin eruption in 100%, OI symptoms in 79.5%,joint problems in 59.5% and renal involvement in 26.5% of cases. Thrombocytosis in 31 % and increased ESR in 55% of cases were the main significant laboratory findings. Abdominal sonography was done in 58 cases with GI symptoms, and was abnormal in 28 cases (48%): free peritoneal fluid in 26%, thickened bowel wall in 14%, ileus in 5% and intussusception in 3%. Sixty percent of the patients received prednisolone for OI problems or renal involvement. Nine percent of the cases had relapse and there was no death. It was concluded that: a) There is no significant sex difference in children with HSP in this area. b) The age of children with HSP in this area is the same as those in eastern countries, but relatively higher than that reported in western countries. c) Abdominal sonography can be a helpful means of diagnosis in patients with OI manifestations of HSP before skin eruption. d) The morbidity and mortality of HSP is very low if the disease is diagnosed in its early stages and managed properly.
similar resources
henoch-schonlein purpura in children: our experience with 165 cases from southern iran
during a 6 year period from september 1992 to september 1998, 165 children with a final diagnosis of henoch-schonlein purpura (hsp) were managed and followed in our center. there were 87 (52%) boys and 78 (48%) girls, with age ranges of 1-16 years and mean age of 7.8 years. forty-one percent of the patients had evidence of preceding upper respiratory tract infection (uri). the main clinical fea...
full textHenoch Schonlein Purpura in children: clinical analysis of 120 cases.
BACKGROUND Henoch Schonlein Purpura (HSP) is a systemic vasculitic disease which is common in children. It is very important to understand the clinical features of this disease for doctors and nurses. OBJECTIVES To study the clinical characteristics of HSP in children. METHODS Collect the clinical data of the HSP children, and analyze the clinical characteristics of these HSP patients. RE...
full textHenoch-Schonlein purpura: the Chandigarh experience.
OBJECTIVE To determine the clinical profile of children with Henoch-Schonlein purpura (HSP). DESIGN Hospital based descriptive follow-up study. SUBJECTS 45 patients attending the Pediatric Rheumatology and Immunology clinic over the last 4 years. RESULTS The patients were aged between 2.5-12 years with a male to female ratio of 2:1. All cases had palpable purpura. Gastrointestinal involve...
full textHenoch-Schonlein purpura.
1 of 1 DESCRIPTION A 63-year-old man with a history of intermittent vasculitic rash presented with an acute abdomen. Findings at laparotomy were consistent with patchy serosal small vessel vasculitis. The patient was well and walking around the ward 24 h later after intravenous methylprednisolone. In this case no biopsy was taken. The diagnosis was made clinically given the history of intermitt...
full textHenoch-Schonlein purpura.
Henoch-Schönlein purpura (HSP) is a small vessel vasculitis that annually affects 10 to 20 children per 100,000 population. It is the most common vasculitis of childhood. Although HSP is seen in infancy through adulthood, most documented cases affect children; more than 75% of those diagnosed as having HSP are younger than 10 years, with a peak incidence at 4 to 6 years. White and Asian childre...
full textMy Resources
Journal title
volume 16 issue 1
pages 5- 8
publication date 2002-05
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023